Sermorelin Acetate

Sermorelin selectively binds to GHRH receptors on anterior pituitary somatotroph cells, activating intracellular signalling pathways that stimulate the pituitary release of endogenous growth hormone. Experimental investigations have characterized its receptor-binding properties, G protein-coupled signalling mechanisms, and downstream endocrine responses, making it a well-characterized research compound for studying growth hormone regulation.

Research Applications

• Growth hormone-releasing hormone (GHRH) signalling studies
• GHRH receptor pathway investigations
• Growth hormone secretion dynamics research
• Hypothalamic-pituitary axis studies
• GH/IGF-1 axis investigations